Position in NYXH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,562
-$2,593 QoQ
Shares Held
4,475
+28.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 45 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NYXH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $11,057,130,177 across 128 Medical Devices names. NYXH ranks #106 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
26,611,315 | $2,414,710,711 | |
| 2 | SYK |
Stryker Corp
|
5,960,732 | $1,876,676,853 | |
| 3 | MDT |
Medtronic plc
|
19,444,871 | $1,521,172,249 | |
| 4 | STE |
STERIS plc
|
3,950,067 | $831,765,599 | |
| 5 | BSX |
Boston Scientific Corp
|
18,947,147 | $808,664,224 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,339,368 | $573,459,221 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
6,223,322 | $398,354,834 | |
| 8 | DXCM |
Dexcom Inc
|
5,156,282 | $347,275,584 |
All Filings in NYXH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,562 | 4,475 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,155 | 3,478 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,785 | 1,475 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $11,385 | 2,475 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $18,513 | 2,475 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $19,090 | 2,735 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,888 | 1,236 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,253 | 236 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6 | 1 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||